Abstract
The present study analyzed the correlation of DNA polymerase β (DNA polβ) promoter mutations and activity in esophageal squamous cell carcinoma (ESCC). The DNA polβ promoter was amplified from 108 ESCC samples and adjacent paracancerous samples by PCR and cloned into the pGL3-enhancer luciferase vector. The recombined vectors were transfected into esophageal carcinoma cells (EC9706, Eca109, and KYSE30), and luciferase activity was detected using dual luciferase reporter gene technology. Eleven polβ promoter mutations were identified and submitted to GenBank. The mutation rate of the DNA polβ promoter was higher in ESCC tissues (36/108, 33.3 %) than in the paired paracancerous tissues (21/108, 19.4 %) (P = 0.021). The C → A mutation at locus −37 was the hotspot mutation in cancerous tissues, and its frequency was higher in ESCC tissues (26/108) than in paracancerous tissues (7/108) (P = 0.00). The highest relative luciferase activity (RLA) was observed in the DNA polβ promoter, with a C → A mutation at −37. Significant differences in RLA were observed between mutant DNA polβ promoters (except for C detected at −19, T → C at −194, C → A at −37, and T → C at 30) and the wild-type DNA polβ promoter (P = 0.000), and RLA was significantly higher in ESCC tissues than in paracancerous tissues (P = 0.003). Our findings suggest that the upregulation of transcriptional activity induced by mutations in the DNA polβ promoter in ESCC tissues may be one of the molecular mechanisms mediating abnormal overexpression of DNA polβ in ESCC.
Similar content being viewed by others
References
Idriss HT, Al-Assar O, Wilson SH. DNA polymerase beta. Int J Biochem Cell Biol. 2002;34(4):321–4.
Bergoglio V, Pillaire MJ, Lacroix-Triki M, Raynaud-Messina B, Canitrot Y, Bieth A, et al. Deregulated DNA polymerase beta induces chromosomal instability and tumorigenesis. Cancer Res. 2002;62:3511–4.
Canitrot Y, Frechet M, Servant L, Cazaux C, Hoffmann JS. Overexpression of DNA polymerase beta: a genomic instability enhancer process. FASEB J. 1999;13:1107–11.
Canitrot Y, Cazaux C, Fréchet M, Bouayadi K, Lesca C, Salles B, et al. Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs. Proc Natl Acad Sci USA. 1998;95:12586–90.
Zhao GQ, Wang T, Zhao Q, Yang HY, Tan XH, Dong ZM. Mutation of DNA polymerase beta in esophageal carcinoma of different regions. World J Gastroenterol. 2005;11:4618–22.
Ziming D, Guoqiang Z, Qin Z, Hongyan Y, Lexun X, Xiaohui T, et al. A study of DNA polymerase β mutation in human esophageal cancer. Natl Med J China. 2002;82(13):899–902.
Guoqiang Z, Wei H, Qin Z, Han Z, Jie Z, Ziming D. Detection of DNA polymerase β mutation in human gastric cancer tissue. J Zhengzhou Univ (Sci Med). 2005;40(4):598–600.
Iwanaga A, Ouchida M, Miyazaki K, Hori K, Mukai T. Functional mutation of DNA polymerase beta found in human gastric cancer—inability of the base excision repair in vitro. Mutat Res. 1999;435(2):121–8.
Donigan KA, Hile SE, Eckert KA, Sweasy JB. The human gastric cancer-associated DNA polymerase β variant D160N is a mutator that induces cellular transformation. DNA Repair (Amst). 2012;11(4):381–90.
Lang T, Maitra M, Starcevic D, Li SX. Sweasy JB.A DNA polymerase beta mutant from colon cancer cells induces mutations. Proc Natl Acad Sci USA. 2004;101:6074–9.
Donigan KA, Sun KW, Nemec AA, Murphy DL, Cong X, Northrup V, Zelterman D, Sweasy JB. The Human POLB Gene is Mutated in a High Percentage of Colorectal Tumors. J Biol Chem. 2012;287: 23830–9.
Bergerheim US, Kunimi K, Collins VP, Ekman P. Deletion mapping on chromosomes8, 10, and 16 im human prostatic carcinoma. Gene Chromosom Cancer. 1991;3(3):215–20.
Dobashi Y, Shuin T, Tsuruga H, Uemura H, Torigoe S, Kubota Y. DNA polymerase beta gene mutation in human prostate cancer. Cancer Res. 1994;54(9):2827–9.
Bhattacharyya N, Chen HC, Grundfest-Broniatowski S, Banerjee S. Alteration of hMSH2 and DNA polymerase beta genes in breast carcinoma and fibroadenomas. Biochem Biophy Res Commun. 1999;259(2):429–35.
Marian E. Eydmann, Knowles MA. Mutation analysis of 8p gene POLB and PPP2CB in bladder cancer. Cancer Res. 1997;93(2):167–71.
Hong Z, Ming-shan L, Guo-qiang Z, Zi-ming D. Study on DNA polymerase β gene mutation in human nasopharyngeal cancer. Cancer Res Prev Treat. 2007;34(5):340–1.
Li G, Guoqiang Z, Xiwen S, Wei H, Ziming D. Detection of DNA polymerase β gene mutation in human gliomas tissue. J Zhengzhou Univ (Sci Med). 2005;40(4):605–8.
Bhattacharyya N, Chen HC, Wang L, Banerjee S. Heterogeneity in expression of DNA polymerase beta and DNA repair activity in human tumor cell lines. Gene Expr. 2002;10(3):115–23.
Chan K, Houlbrook S, Zhang QM, Harrison M, Hickson ID, Dianov GL. Overexpression of DNA polymerase beta results in an increased rate of frameshift mutations during base excision repair. Mutagenesis. 2007;22(3):183–8.
Nicolay NH, Helleday T, Sharma RA. Biological relevance of DNA polymerase β and translesion synthesis polymerases to cancer and its treatment. Curr Mol Pharmacol. 2012;5(1):54–67.
Albertella MR, Lau A, O'Connor MJ. The overexpression of specialized DNA polymerases in cancer. DNA Repair (Amst). 2005;4(5):583–93.
Srivastava DK, Husain I, Arteaga CL, Wilson SH. DNA polymerase β expression differences in selected human tumors and cell lines. Carcinogenesis. 1999;20(6):1049–54.
Long F, Wang C, Xu B, Liu Z, Huang L. Expression of DNA polymerase-β (DNA polβ) and ferritin (FT) and clinicopathological significances in the benign ad malignant lesions of ovarian. J Med Res. 2008;37(3):57–9.
Guoqiang Z, Tao W, Mingyao Z, Wei H, Hongyan Y, Mingchen W, et al. Detection of DNA polymerase β mRNA in esophageal carcinoma tissue. J Zhengzhou Univ (Sci Med). 2005;40(4):603–5.
Naigang Z, Shikun L, Jinglan W, Ziming D. DNA polymerase β gene expression in human esophageal cancer tissues. J Zhengzhou Univ (Sci Med). 2003;38(4):501–3.
Widen SG, Kedar P, Wilson SH. Human beta-polymerase gene. Structure of the 5′-flanking region and active promoter. J Biol Chem. 1988;263(32):16992–8.
Acknowledgments
This study was supported by National Natural Science Foundation of China, no. 81272188.
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, M., Zang, W., Wang, Y. et al. DNA polymerase β promoter mutations and transcriptional activity in esophageal squamous cell carcinoma. Tumor Biol. 34, 3259–3263 (2013). https://doi.org/10.1007/s13277-013-0898-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-013-0898-5